Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Proposal for the Retrospective Identification and Categorization of Older People With Functional Impairments in Scientific Studies-Recommendations of the Medication and Quality of Life in Frail Older Persons (MedQoL) Research Group.
Brefka S, Dallmeier D, Mühlbauer V, von Arnim CAF, Bollig C, Onder G, Petrovic M, Schönfeldt-Lecuona C, Seibert M, Torbahn G, Voigt-Radloff S, Haefeli WE, Bauer JM, Denkinger MD; Medication and Quality of Life Research Group. Brefka S, et al. J Am Med Dir Assoc. 2019 Feb;20(2):138-146. doi: 10.1016/j.jamda.2018.11.008. Epub 2019 Jan 9. J Am Med Dir Assoc. 2019. PMID: 30638832 Free article.
Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials.
Seibert M, Mühlbauer V, Holbrook J, Voigt-Radloff S, Brefka S, Dallmeier D, Denkinger M, Schönfeldt-Lecuona C, Klöppel S, von Arnim CAF. Seibert M, et al. Alzheimers Res Ther. 2021 Jul 16;13(1):131. doi: 10.1186/s13195-021-00867-8. Alzheimers Res Ther. 2021. PMID: 34271969 Free PMC article.
Neurocognitive function as outcome and predictor for prefrontal transcranial direct current stimulation in major depressive disorder: an analysis from the DepressionDC trial.
Soldini A, Vogelmann U, Aust S, Goerigk S, Plewnia C, Fallgatter A, Normann C, Frase L, Zwanzger P, Kammer T, Schönfeldt-Lecuona C, Vural G, Bajbouj M, Padberg F, Burkhardt G. Soldini A, et al. Among authors: schonfeldt lecuona c. Eur Arch Psychiatry Clin Neurosci. 2024 Feb 26. doi: 10.1007/s00406-024-01759-2. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38407625
Adverse childhood experiences and clinical effects of transcranial direct current stimulation in major depressive disorder: Results from the DepressionDC trial.
Burkhardt G, Goerigk S, Bulubas L, Dechantsreiter E, Keeser D, Kumpf U, Soldini A, Wolf J, Amann BL, Plewnia C, Fallgatter A, Langguth B, Normann C, Frase L, Zwanzger P, Kammer T, Schönfeldt-Lecuona C, Kamp D, Bajbouj M, Falkai P, Brunoni AR, Bertsch K, Jobst A, Reinhard MA, Padberg F. Burkhardt G, et al. Among authors: schonfeldt lecuona c. Psychiatry Res. 2023 Dec;330:115577. doi: 10.1016/j.psychres.2023.115577. Epub 2023 Oct 29. Psychiatry Res. 2023. PMID: 37922733 No abstract available.
189 results